In a previous study, we detected a 6p25-p24 region linked to schizophrenia in families with high composite cognitive deficit (CD) scores, a quantitative trait integrating multiple cognitive measures. Association mapping of a 10 Mb interval identified a 260 kb region with a cluster of single-nucleotide polymorphisms (SNPs) significantly associated with CD scores and memory performance. The region contains two colocalising genes, LYRM4 and FARS2, both encoding mitochondrial proteins. The two tagging SNPs with strongest evidence of association were located around the overlapping putative promoters, with rs2224391 predicted to alter a transcription factor binding site (TFBS). Sequencing the promoter region identified 22 SNPs, many predicted to affect TFBSs, in a tight linkage disequilibrium block. Luciferase reporter assays confirmed promoter activity in the predicted promoter region, and demonstrated marked downregulation of expression in the LYRM4 direction under the haplotype comprising the minor alleles of promoter SNPs, which however is not driven by rs2224391. Experimental evidence from LYRM4 expression in lymphoblasts, gel-shift assays and modelling of DNA breathing dynamics pointed to two adjacent promoter SNPs, rs7752203-rs4141761, as the functional variants affecting expression. Their C-G alleles were associated with higher transcriptional activity and preferential binding of nuclear proteins, whereas the G-A combination had opposite effects and was associated with poor memory and high CD scores. LYRM4 is a eukaryote-specific component of the mitochondrial biogenesis of Fe-S clusters, essential cofactors in multiple processes, including oxidative phosphorylation. LYRM4 downregulation may be one of the mechanisms involved in inefficient oxidative phosphorylation and oxidative stress, increasingly recognised as contributors to schizophrenia pathogenesis.
Introduction
Schizophrenia is a complex disorder with variable expression, ill-defined phenotype boundaries and poorly understood multifactorial aetiology, which involves a significant but likely heterogeneous genetic contribution. 1, 2 Most diagnostic criteria remain symptom-based, relying largely on the interpretation of the patients' self-reported subjective experiences. As a result, the fundamental problem of 'connecting the phenotype with the genotype' 3 is likely to persist in the new era of powerful genetic technologies.
Hypotheses-guided endophenotype-based studies offer an approach to reducing the heterogeneity of schizophrenia as an alternative or a complement to symptom-based phenotypes. Consistent evidence suggests that measures of neurocognitive dysfunction provide the largest effect sizes among candidate endophenotypes. [4] [5] [6] Patterns of memory impairment, providing a strong signal against a background of generalised cognitive deficit (CD), have been replicated across studies and are present in a substantial proportion of schizophrenia patients. 7 As most of the neurocognitive tests tap into several component processes, composite endophenotypes, integrating multiple measures, are more likely to capture variation that is genetically influenced than single-feature endophenotypes.
The Western Australian Family Study of Schizophrenia (WAFSS) applied multi-domain endophenotyping to tease out subtypes based on objective measurement of cognitive dysfunction and to explore their genetic underpinnings. The cognitive measures employed were aggregated into a limited number of quantitative traits, using grade of membership analysis. [8] [9] [10] Grade of membership (GoM) is a version of latent structure analysis, which defines latent groups ('pure types') and allows individuals to resemble each pure types to a quantifiable degree. Two pure types represented > 90% of schizophrenia patients, yielding distinct cognitive patterns: one of generalised cognitive deficit and one cognitively spared. The CD phenotype is relatively homogeneous and displays pervasive deficit across cognitive domains, with the most prominent dysfunctions involving verbal memory, sustained attention/working memory and general intelligence. 10 It is further characterised by early developmental delays, poor scholastic performance and social skills, and a clustering of soft neurological signs. 11 Our genome-wide linkage analysis of schizophrenia, using ordered subsets with the composite CD scores as covariate, identified 6p25-p24 as the best region, with a logarithmic odds score of 3.3 contributed exclusively by the CD families. 10 The short arm of chromosome 6 is among the best replicated in linkage studies of schizophrenia, with two loci (6pter-p22.3 and 6p22.3-p21.1) pointing to the possible presence of more than one susceptibility gene. 12 Here we present the follow-up investigations of our 6p25-p24 linkage findings. Association mapping and functional analyses (luciferase reporter assays, site-directed mutagenesis, gene expression in lymphoblasts, gel-shift experiments and computer modelling) implicate two colocalising genes encoding mitochondrial proteins in CD in schizophrenia, with stronger evidence favouring LYMR4 as the candidate. The data add to the accumulating evidence of mitochondrial dysfunction contributing to the pathogenesis of the disorder. 13 
Materials and methods

Subjects
The discovery sample comprised 583 subjects of European ancestry ( > 75% Anglo-Irish): 381 schizophrenia patients (mean age 33.9, range 17-60 years) recruited from consecutive admissions to psychiatric hospitals or community mental health centres, and 202 controls (mean age 39.6, range 17-76 years) randomly sampled from local telephone directories, or among Red Cross blood donors, and screened for psychopathology to exclude those with personal or family history of psychotic illness. Later in the study, the WAFSS sample was expanded by 126 cases (mean age 39.7, range 18-65 years) and 80 controls (mean age 39.1, range 18-59 years) to a total of 789 participants (507 cases, 282 controls) (demographics in Supplementary Table 1) . Written informed consent was obtained from all subjects. The study was approved by the Human Research Ethics Committee of The University of Western Australia.
Diagnostic assessment was based on a modification of the Schedules for Clinical Assessment in Neuropsychiatry interviews, 14 scored using the OPCRIT algorithm. 15 Video-recorded interviews and clinical charts were independently reviewed by two senior clinicians who assigned consensus research International Classification of Diseases, 10th edition and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition diagnoses of schizophrenia and spectrum disorders. 2 Patients and controls were administered a battery of tests assessing neurocognitive performance. 10 Data from the multiple neurocognitive domains were integrated into the CD and cognitively spared composite continuous traits [8] [9] [10] (Supplementary Methods and Supplementary Table 1 ). In addition, 485 cases were examined for soft neurological signs using the Neurological Evaluation Scale. 16 An independent ethnically matched Irish replication sample (Trinity College, Dublin, Ireland) included 288 schizophrenia cases and 172 controls, where cognitive assessment similar to WAFSS allowed comparisons of individual test results and an estimation of CD scores (please see Phenotype definition section in Supplementary Methods).
The question whether the findings could be extended to normal cognitive function and age-related decline was addressed in a sample of 521 normal ageing men (age X65 years, mean 76.6, range 71-87 years), recruited randomly from the electoral roll-all 6p25 genes and cognitive deficit in schizophrenia A Jablensky et al living independently in the community and volunteering to participate in the Health In Men Study. 17, 18 Memory performance had been assessed using the California Verbal Learning Test (CVLT-II). . Association with disease outcome was analysed in the schizophrenia-controls discovery sample using w 2 goodness-of-fit test of allelic association (1-degree-of-freedom). Association with quantitative traits scores was analysed using linear regression on number of alleles as implemented in PLINK 1.06. 19 For each trait, phenotypes were randomly permuted as described below to calculate empirical P-values corrected for all markers tested. Permutation correction ensured that the P-values for non-normal traits (composite CD scores) were valid.
SNP genotyping
Permutation-based point-wise (uncorrected) P-values were calculated using adaptive permutation (--aperm in PLINK). For CD and RAVLT-DW scores, P-values corrected for multiple testing were obtained by calculating the highest test statistic across all SNPs from each of 10 000 permutations, with corrected empirical P-values obtained by comparing the observed test statistic with permutation results (--mperm in PLINK).
To test whether there was strong signal in the top 10 most significant SNPs, we employed a multiple test statistic (T)Àthe sum of the square of the t-statistics from the linear regression. Empirical significance was established by 10 000 permutations and comparing the observed T with that seen in each permutation replicate.
We also examined if the top 10 SNPs were more significantly clustered than expected by chance given the linkage disequilibrium (LD) pattern across the region. A clustering metric calculated on the empirical data was compared with the same metric applied to permutation replicates, where phenotype labels are repeatedly shuffled. Performing permutations in this way preserved the original LD structure. The ad hoc clustering metric was the variance of the physical distances (kb) between the top 10 SNPs, with end points explicitly included (even if the selected SNPs are not at the end points). This variance takes high values when there is strong clustering in the data and low values for no clustering (SNPs spread evenly over the region with similar inter-marker distances). The actual values of the association test statistic are not included, only the top 10 SNPs and their physical locations. The variance of the physical distances in the real data was compared with the variance from 10 000 permutation replicates and empirical P-values calculated. Although physical distances do not necessarily correlate highly with LD, as the observed LD structure is preserved in the permutations, any increased clustering due simply to LD is appropriately taken into account. This test is region-wide and no further correction for multiple testing is required.
Bioinformatics analysis
The genomic structure of the region harbouring the cluster of associated SNPs was examined in the UCSC Genome Browser. NCBI databases were used for checking polymorphisms in the region (dbSNP build 130) and expression data (GEOprofiles). LD was analysed in HaploView. 20 SNP-related changes in transcription factor binding sites (TFBS) were explored using TESS (http://www.cbil.upenn.edu/tess), CONSITE 21 and Genomatix (http://www.genomatix.de/ en/produkte/genomatix-software-suite.html). The SNPExpress database 22 was searched for association between SNPs of interest and gene expression data. URLs are listed as Supplementary Information. Postnatal LYRM4 and FARS2 expression in the brain. Postnatal developmental regulation of transcription was examined in our previously published microarray expression data 23 by specifically analysing LYRM4 and FARS2 levels. The expression analysis was conducted on total RNA from grey matter of the middle frontal gyrus (Brodman's area 46), obtained from 45 post-mortem brain samples grouped into neonates, infants, toddlers, school-age, teenagers, young adults and adults. 23 Published LYRM4 and FARS2 expression data. RAW Affymetrix CEL files for microarray experiments were downloaded from the NCBI Gene Expression Omnibus database. Results from each study were normalised using the robust multi-array average algorithm available in the Affymetrix package of Bioconductor (Santa Clara, CA, USA). Mean log-normalised expression values were compared with a t-test to determine significant differences between sample groups for the probe sets representing LYRM4 and FARS2.
Genomic and functional analyses
Luciferase reporter assays. Promoter activity, the effect of DNA polymorphisms on expression, and the role of associated rs2224391 were examined in reporter assays. The polymerase chain reaction (PCR) amplified 1988bp fragment was cloned in a Firefly luciferase reporter plasmid in two orientations, following the direction of gene transcriptionforward (FARS2) and reverse (LYRM4), each in two versions-homozygous for the major versus the minor SNP alleles haplotype. The individual effect of rs2224391 was analysed by site-directed mutagenesis targeting that SNP alone while preserving the remaining haplotype background, that is, introducing the minor rs2224391 allele into the major haplotype and vice versa. Plasmids were transiently co-transfected with a normalising Renilla luciferase reporter into neuroblastoma SH-SY5Y and HEK293 cells.
Gene expression in LCLs. LYRM4 (exons 1 and 2) mRNA levels were determined in 249 LCLs using quantitative PCR with the house-keeping gene HPRT1 for normalisation. Association with promoter SNPs was analysed in SimHap. 24 Gel-shift assays. Gel-shift experiments tested the sequence specificity and the effect of SNP alleles on the binding of nuclear proteins. A biotin-labelled oligonucleotide containing the SNPs of interest was incubated with nuclear extracts from SH-SY5Y cells. Formation of complexes with transcription machinery proteins was monitored on an electrophoretic gel. The specificity of binding was assessed in self-and cross-competition assays with nonlabelled oligonucleotides, identical respectively to the test sequence or containing the alternative SNP alleles. Interference with DNA-protein interactions was investigated by the addition of antibodies targeting specific transcription factors, to determine the identity of the protein(s) driving the interaction.
Promoter DNA breathing dynamics. A recently developed computational approach 25, 26 was applied independently to model the effect of SNPs on DNA breathing dynamics (the propensity of the sequence to form 'bubbles' necessary for the binding of the transcription machinery). Langevin molecular dynamic simulations, based on the Extended Peyrard-Bishop-Dauxois nonlinear model of DNA, 27 assessed bubble-formation probability, bubble lifetime and average strand separation as the mechanistic parameters characterising the transcriptional activity of the sequence. The simulations were run as described 25, 28 on Linux clusters at the Los Alamos National Laboratory and Harvard Medical School.
Mitochondrial protein synthesis and steady-state mitochondria-encoded protein abundance. De novo mitochondrial protein synthesis was studied by incorporating 35 S-labelled methionine and cysteine in mitochondrial proteins in LCLs from subjects homozygous for the major or minor SNP haplotype, after inhibition of cytoplasmic protein translation with emetine. Steady-state levels of mitochondriaencoded proteins were analyzed by immunoblotting using mouse aCOX1 and aNDI antibodies and porin as a loading control.
Results
A 260 kb region associated with measures of cognitive dysfunction Analysis of association with clinical schizophrenia identified SNPs scattered across multiple genes with marginal results (Supplementary Table 3) , none of which withstood correction for multiple testing. In contrast, the use of quantitative cognitive measures identified a cluster of SNPs spanning 260 kb on 6p25.1, associated (at P < 0.001) with composite CD and memory (RAVLT-DW) scores (Figure 1 , Table 1  and Supplementary Table 4 ). After correction for multiple SNPs, two variants remained significantly associated: rs17736905 with CD scores (P = 0.029) and rs2503812 with RAVLT-DW (P = 0.026). Analysis considering the summed test statistics of the top 10 SNPs generated a P-value of 0.0109 for CD scores and 0.0028 for RAVLT-DW (corrected for multiple markers), with study-wide P-values (corrected for eight phenotypes) 0.087 for CD and 0.0224 for RAVLT-DW. Testing if the clustering of the top 10 SNPs was more significant than expected, given the LD pattern, generated a P-value of 0.0010 for CD scores and 0.0039 for RAVLT-DW (study-wide P-values 0.008 for CD scores and 0.0312 for RAVLT-DW).
In the Irish sample, replication analysis of the four top SNPs (Table 1) supported association, with an identical direction of the effect, of memory performance (based on the Logical Memory delayed subtest from the Wechsler Memory Scale) with rs2145372 (P = 0.019) and rs2224391 (P = 0.037), and a trend for rs2875980 (P = 0.055; correlated with rs17736905). Estimated CD scores were significantly associated with rs2145372 (P = 0.035). No significant results were obtained for rs2503812 ( Table 1) . The two SNPs supported by the replication, rs2145372 (allele G) and rs2224391 (allele C), were analysed further in the newly recruited WAFSS participants and jointly in the entire WAFSS sample. Both showed association in the new sample, as well as in the entire data set, with highly significant P-values for both CD scores and memory performance (Table 1) . Word list learning (as in RAVLT and CVLT-II) and logical memory (WMS-R) target similar or overlapping functions 6p25 genes and cognitive deficit in schizophrenia A Jablensky et al Table 1 Genetic association of 6p25.1 SNPs and cognitive endophenotypes In WAFSS cases, testing for association with soft neurological signs (prevalent in patients with CD) revealed nominally significant results for signs of impaired motor coordination: rs2145372, P = 0.033 and rs2224391, P = 0.026 (Table 2 and Supplementary  Table 5 ). The other two components of the test battery showed no association.
In the sample of normal ageing men, verbal memory showed no association with either rs2145372 (P = 0.37) or rs2224391 (P = 0.13). This negative result could point to different mechanisms in age-related cognitive decline or to additional, age-related factors (for example, hypertension, stroke and diabetes, and so on), 18 masking the association in the Health In Men Study sample (mean age 76.6 years) compared to schizophrenia (mean age 33.9 years).
Two colocalising genes encoding mitochondrial proteins
The region contains two genes on the opposite DNA strands, LYRM4 and FARS2, with overlapping predicted promoters (Figure 1) . FARS2 encodes the mitochondrial isoform of phenylalanine-tRNA synthetase, a member of an ancient family of enzymes, which catalyse the attachment of specific amino acids to their cognate tRNAs, thus 'establishing the rules of the genetic code'. 31 Mutations in other aminoacyl-tRNA synthetases (ARS) are known to result in disorders affecting the peripheral as well as central nervous system. 31, 32 LYRM4 encodes another mitochondrial protein (known in the biochemical literature as ISD11)-a eukaryote-specific component of the ISCU/NFS1/LYRM4 mitochondrial complex responsible for the biogenesis of Fe-S (iron-sulphur) clusters, essential cofactors in a variety of processes, including electron transfer during oxidative phosphorylation. [33] [34] [35] [36] LYRM4 is a stabiliser of the Fe-S cluster assembly platform, where it interacts directly with the complex-activating protein frataxin, which is mutated in Friedreich's ataxia. 33, 34, 36 Neither gene is an obvious candidate.
The top two consistently associated SNPs, rs2224391 and rs2145372 (D 0 = 0.96, r 2 = 0.65), are within or close to the shared promoters (Figure 1) . The SNPExpress database reports association between rs2224391 and brain mRNA levels of both genes, with different directions of the effects: higher FARS2 and lower LYRM4. Direct rs2224391 involvement in transcription regulation was suggested by all three bioinformatic programs (see Materials and methods) predicting loss of a GATA1/3 binding site due to the A > C transversion. At the same time, dbSNP listed additional polymorphisms in the predicted promoters, prompting us to characterise fully the diversity in our sample. Sequencing analysis of the predicted promoters identified 22 SNPs (Supplementary Figure 1 ) in a tight LD block (D 0 B1.0; r 2 > 0.7, broken between rs2224391 and rs4141761) with many predicted to affect TFBS.
The significantly associated SNPs around the putative overlapping promoters, the reported association of rs2224391 with mRNA levels and its predicted direct effect on TFBS, and the presence of other, correlated and possibly functional, polymorphisms in the promoter region focused our subsequent analyses on expression regulation.
LYRM4 is developmentally regulated
Expression microarray data in GEOProfiles showed rising Lyrm4 (P = 0.001), but not Fars2 (P = 0.263) brain mRNA levels from mouse embryonic day e11.5 (onset of neuronal differentiation) to day e13.5 (peak of neurogenesis) (GEOrecord GDS3442). Our analysis of prefrontal cortex LYRM4 and FARS2 mRNA levels in individuals aged 0-50 years demonstrated increasing expression parallel to postnatal brain maturation and intensifying neuronal activity and energy demands. We found a significant, high magnitude, increase for LYRM4 mRNA (r = 0.75, P < 0.00001; ANOVA, P = 3.9E-5) and less steep, but still significant Abbreviations: CI, confidence interval; NES, Neurological Evaluation Scale; OR, odds ratio; SNP, single-nucleotide polymorphism; WAFSS, Western Australian family Study of Schizophrenia. Affected subjects were examined using the NES. 16 The estimates above are based on the presence of one or more pathological sign in the respective category. a Tandem walk, Romberg, diadochokinesis, finger-nose and finger-thumb tests. b Adventitious overflow, mirror movements. c Rhythm tapping, fist-ring and fist-edge-palm tests.
6p25 genes and cognitive deficit in schizophrenia A Jablensky et al for FARS2 (r = 0.515, P < 0.001; ANOVA, P = 0.014) (Supplementary Figure 2) . The data suggest that both genes, particularly LYRM4, are upregulated in the first decade of human life and that increased synthesis of these gene products occurs until around adolescence, coincident with the typical onset of schizophrenia. Further GEOProfile searches revealed downregulation of LYRM4 (P = 0.009), but not FARS2 (P = 0.205) expression in the cerebellar cortex of schizophrenia patients compared with controls (GEOrecord GSE4036), and of Lyrm4 (P = 6.15e-05), but not Fars2 (P = 0.058) in the prefrontal cortex of mice with microdeletions in the locus syntenic to human 22q11.2 (GEOrecord GSE10784).
Lower LYRM4 expression under the minor promoter SNP haplotype Reporter assays showed that luciferase expression in the test constructs was comparable to that under the strong SV40 promoter and 50-to 100-fold higher than that in the plasmid without promoter (Figure 2 ). This confirmed that promoters driving transcription in both orientations are present in the cloned fragments. (Figure 2 ). Site-directed mutagenesis, changing rs2224391 alleles while preserving the haplotype background, had a modest effect on expression in the LYRM4 orientation (P = 0.013) and no effect in the FARS2 orientation (P = 0.24) (Figure 2) . Quantitative LYRM4 mRNA analysis in 249 LCLs showed lack of effect of rs2224391 (mean level in minor allele homozygotes 0.89 (s.e. 0.08); mean levels in major allele carriers, hetero-and homozygotes, 0.95-0.97 (s.e. 0.02), P = 0.65). Taken together, these data pointed to LYRM4 as the gene whose expression levels are markedly regulated by promoter SNPs, and suggested that rs2224391 alone cannot explain the haplotype effects, but may modulate them.
Two adjacent SNPs regulate LYRM4 transcription
In search of the functional variant(s), we next examined a tandem of adjacent SNPs, rs7752203 (C > G)-rs4141761 (A > G), 3 bp apart and predicted to be recognised jointly as TFBS. In the reporter assay, they were represented on the major haplotype as the C-G combination. Analysis of LCL mRNA levels showed significant LYRM4 upregulation in the presence of the rs7752203-rs4141761-C-G haplotype (frequency 0.44): mean mRNA levels 0.99-1.04 in C-G carriers, hetero-and homozygotes, and 0.86 in non-carriers (P = 0.00034). Post-hoc analysis of the effect of rs7752203-rs4141761 on cognitive performance in the expanded WAFSS sample showed association of the G-A haplotype with lower RAVLT-DW (b-coefficient = À0.83; P = 0.0025) and higher CD scores (b-coefficient = 0.07; P = 0.0004). 6p25 genes and cognitive deficit in schizophrenia A Jablensky et al Direct evidence of the involvement of these two SNPs in transcriptional regulation was obtained in gel-shift assays, where the biotin-labelled oligonucleotide probe containing the rs7752203-rs4141761-C-G sequence (and no other polymorphisms) identified two bands of presumably different protein composition, where specific binding was demonstrated by decreasing band intensity in the selfcompetition assay (Figure 3a) . Preferential binding to the C-G sequence, especially of complex A, was supported by the cross-competition experiment where the G-A oligonucleotide was inefficient in displacing the C-G self-probe. The results suggest that the rs7752203-rs4141761 effect on transcription is direct and not a reflection of other correlated polymorphisms. Pretreatment with antibodies, targeting transcription factors predicted to recognise the oligonucleotide sequence, showed consistently diminished or absent band A after treatment with the antibody against nuclear factor-kB (NF-kB) subunit p50 (Figure 3b ), suggesting that NF-kB may be the transcription factor involved in the preferential C-G binding.
Independently and blind to the experimental data, computer modelling revealed significant sequence effects on DNA breathing dynamics (Figure 3c) . The simulations identified a fragment encompassing rs7752203-rs4141761, where the C-G sequence displayed high breathing probability, 9-10 bp bubble length and B6 ps lifetime-parameters characterising sites with strong specific binding of the transcription machinery. 26 
Discussion
Our previous study of a modest number of schizophrenia families identified linkage to 6p25-p24 as a result of the dissection of the heterogeneous clinical phenotype by incorporating neurocognitive features in its characterisation. 10 In the present follow-up association analysis, clinical schizophrenia produced predictably unremarkable results, whereas the use of quantitative endophenotypes allowed us to refine a 10 Mb region with 46 positional candidates to a 260 kb interval containing only two genes. The strongest evidence of association, based on three different approaches to the statistical analysis, was obtained for the composite CD scores, in logical continuity with our linkage results, and with memory, a cognitive domain impaired early in the Figure 3 Gel-shift experiments and computer modelling of DNA breathing dynamics. At the top, sequence examined in the computer simulations, with the oligonucleotide probe used in gel-shift experiments underlined. Single-nucleotide polymorphisms (SNPs) rs7752203, rs4141761 and rs2224391 (left to right, italicised and in red) are shown as the major haplotype. The LYRM4 transcription start site is bolded and in green. (a) Gel-shift assay with nuclear extracts prepared from neuroblastoma SH-SY5Y cells and rs7752203-rs4141761-C-G as probe. Unlabelled oligonucleotides used in the self-and cross-competition assays are shown on top, with triangles indicating increasing concentrations (20-/100-fold molar excess) of the competitor. Lanes: 1, no nuclear extract; 2, no competitor; 3 and 4, self-competitor; and 5 and 6, cross-competitor. Bands: NS, nonspecific; A and B, specific, with decreasing intensity in the self-competition experiment due to displacement of the labelled probe by the excess of unlabelled oligonucleotide. Preferential binding of the protein complex to the C-G sequence is suggested by the inability of the G-A oligonucleotide to compete out the labelled C-G probe. (b) Treatment of the nuclear extract with antibodies targeting specific transcription factors, before the addition of the oligonucleotide probe. The DNAprotein interaction is blocked by the antibody against nuclear factor-kB (NF-kB) subunit p50, pointing to NF-kB as the transcription factor driving complex A. (c) Computer models of DNA breathing dynamics. Strong breathing activity is predicted for a short sequence containing rs7752203-rs4141761-C-G (left), in contrast to the poor breathing potential of the G-A sequence (right). The white horizontal lines mark the SNP sites. Vertical axis, bubble length in bp; colour axis, bubble lifetime in picoseconds (predicted for DNA openings with amplitude > 3.5 Å ).
6p25 genes and cognitive deficit in schizophrenia A Jablensky et al evolution of the disease and a major contributor to the overall CD. 4, 5, 37 The identification of two colocalising genes, encoding mitochondrial proteins with no immediately obvious relationship to functional deficits in schizophrenia, made the choice of the better candidate a difficult one. Our data pointed to transcriptional regulation as the likely molecular mechanism and favoured LYRM4 as the better candidate based on its developmental regulation, the marked effects of promoter polymorphisms on its expression and existing knowledge of its function. Contrary to bioinformatic predictions, our experimental data did not support rs2224391 and implicated rs7752203-rs4141761 as the regulatory polymorphisms. Experimental evidence was weak for FARS2: associated polymorphisms had a modest effect on expression and no effect on mitochondrial protein translation (Supplementary Figure 3) . One should note however that our experimental system and the use of LCLs may not be an adequate model of living neurons; moreover, ARS mutations can lead to neurological disorders even when aminoacylation is unaffected. 31, 32, 38 Current understanding of proteins is far from complete, and LYRM4/FARS2 co-regulation as a control mechanism for unknown functions remains a possibility.
LYRM4 (ISD11) is part of the assembly platform responsible for the biogenesis of Fe-S clusters, essential cofactors of a variety of proteins involved in electron transfer, enzymatic catalysis, DNA replication and repair, and iron homeostasis. 35, 39, 40 Energy metabolism is highly dependent on the availability of such proteins, as they include Krebs cycle and oxidative phosphorylation components. Defects in the different proteins of the Fe-S cluster assembly complex invariably affect energy metabolism, but show interesting differences in target tissue distributions and phenotypic effects. Mutations in the scaffold protein ISCU cause myopathy with exercise intolerance, 41, 42 whereas frataxin deficiency leads to impaired mitochondrial energy metabolism affecting primarily the dorsal root ganglia, cerebellum and heart muscle. 43, 44 Thus far, ISD11 has not been implicated in a human disease phenotype; however, its knockdown in yeast and human cells results in reduced levels and activity of Fe-S proteins, 33, 34, 45, 46 and we note that lower levels of Fe-S proteins have been reported in post-mortem schizophrenia brains. [47] [48] [49] A commonality of the molecular effects of frataxin and ISD11 deficit is an intriguing hypothetical scenario, supported by the transcriptional co-repression of LYRM4 in Friedreich's ataxia cells 45, 46 and by our observation that SNPs, associated with CD scores and memory, were also associated with motor dyscoordination in our patients.
Mitochondrial dysfunction, which may be the end result of multiple converging processes, is central to senescence and neurodegeneration. [50] [51] [52] Our findings suggest that subtle chronic LYRM4 downregulation could be one of the mechanisms behind impaired oxidative phosphorylation function and oxidative stress in schizophrenia, increasingly recognised as contributors to disease pathogenesis and specifically to impaired cognitive performance in affected subjects. 47, 49, [53] [54] [55] [56] NF-kB, identified in our experiments as a transcription factor regulating LYRM4 expression, is thought to be involved in neuronal growth, differentiation and plasticity, as well as in the response to oxidative stress-a function potentially relevant to LYRM4 regulation. [57] [58] [59] The evolution and findings of this study illustrate the long and convoluted road from genetic association to facing the complexity of molecular pathogenesis.
